Abstract

Focal segmental glomerulosclerosis refers to a set of particular histopathologic lesions in which steroid-resistant podocyte injury leads to patchy adhesions between the glomerular tuft and Bowman's capsule, followed by progressive glomerulosclerosis and proteinuric renal failure. Because of the nonspecific nature of this lesion, it has been difficult to classify the various forms of primary nephrotic syndrome in children. However, with the recognition of hereditary FSGS caused by mutations podocyte slit diaphragm genes, it is increasingly clear that the steroid-resistant form of FSGS that recurs in the renal allografts (R-FSGS) constitutes a distinct clinical entity. Capitalizing on recent studies in which patients have been screened for slit diaphragm gene mutations, this review focuses on the natural history and pathogenesis of R-FSGS.

Highlights

  • R-focal segmental glomerulosclerosis (FSGS) in the Context of Steroid-Resistant Nephrotic SyndromeA recent population-based study in the Gironde region of France reported an incidence of about 2.3 pediatric cases of idiopathic nephrotic syndrome for every 100,000 children

  • Focal segmental glomerulosclerosis refers to a set of particular histopathologic lesions in which steroid-resistant podocyte injury leads to patchy adhesions between the glomerular tuft and Bowman’s capsule, followed by progressive glomerulosclerosis and proteinuric renal failure

  • With the recognition of hereditary focal segmental glomerulosclerosis (FSGS) caused by mutations podocyte slit diaphragm genes, it is increasingly clear that the steroid-resistant form of FSGS that recurs in the renal allografts (R-FSGS) constitutes a distinct clinical entity

Read more

Summary

R-FSGS in the Context of Steroid-Resistant Nephrotic Syndrome

A recent population-based study in the Gironde region of France reported an incidence of about 2.3 pediatric cases of idiopathic nephrotic syndrome for every 100,000 children

The Putative Circulating Podocyte-Toxic Factor in R-FSGS
Pathogenesis of Proteinuria and FSGS Lesions in the Affected Allograft
Treatment of R-FSGS
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call